Skip to content

Medicine Matters

Sharing successes, challenges and daily happenings in the Department of Medicine

Medicine Matters Home Infectious Diseases

Infectious Diseases

Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection

ARTICLE: Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection AUTHORS: Nicole Frumento, Ariadne Sinnis-Bourozikas,… Read More »Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection

Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells

ARTICLE: Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells AUTHORS: Nathan L Board, Zhe Yuan, Fengting Wu, Milica Moskovljevic, Meghana Ravi, Srona Sengupta, Sung Soo Mun, Francesco R Simonetti, Jun… Read More »Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells

Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community

ARTICLE: Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community AUTHORS: Emily A Kendall, Peter… Read More »Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community

Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes

ARTICLE: Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes AUTHORS: Mandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, Sanjay Narayan Gaikwad, Amol Chavan, Sujata Nagnath Dharmashale, Tushar Sahasrabudhe, Rahul Lokhande, Sona Anil Deshmukh, Madhusudan… Read More »Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes

Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors

ARTICLE: Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors AUTHORS: Sara Belga, Sarah Hussain, Robin K Avery, Zeba Nauroz, Christine M Durand, Elizabeth… Read More »Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors

Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis

ARTICLE: Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis AUTHORS: Sadiya Parveen, Jessica Shen, Shichun Lun, Liang Zhao, Jesse Alt, Benjamin Koleske, Robert D Leone, Rana Rais, Jonathan D… Read More »Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis